These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31519879)

  • 1. Comparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes.
    Evangelopoulos D; Prosser GA; Rodgers A; Dagg BM; Khatri B; Ho MM; Gutierrez MG; Cortes T; de Carvalho LPS
    Nat Commun; 2019 Sep; 10(1):4177. PubMed ID: 31519879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance.
    Desjardins CA; Cohen KA; Munsamy V; Abeel T; Maharaj K; Walker BJ; Shea TP; Almeida DV; Manson AL; Salazar A; Padayatchi N; O'Donnell MR; Mlisana KP; Wortman J; Birren BW; Grosset J; Earl AM; Pym AS
    Nat Genet; 2016 May; 48(5):544-51. PubMed ID: 27064254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A preliminary study on the molecular characteristics of D-cycloserine resistance of
    Li C; Li GL; Luo Q; Li SJ; Wang RB; Lou YL; Lyu JX; Wan KL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Feb; 38(2):240-243. PubMed ID: 28231674
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of Alanine Racemase Mutations in Mycobacterium tuberculosis d-Cycloserine Resistance.
    Nakatani Y; Opel-Reading HK; Merker M; Machado D; Andres S; Kumar SS; Moradigaravand D; Coll F; Perdigão J; Portugal I; Schön T; Nair D; Devi KRU; Kohl TA; Beckert P; Clark TG; Maphalala G; Khumalo D; Diel R; Klaos K; Aung HL; Cook GM; Parkhill J; Peacock SJ; Swaminathan S; Viveiros M; Niemann S; Krause KL; Köser CU
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel mutations associated with cycloserine resistance in Mycobacterium tuberculosis.
    Chen J; Zhang S; Cui P; Shi W; Zhang W; Zhang Y
    J Antimicrob Chemother; 2017 Dec; 72(12):3272-3276. PubMed ID: 28961957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis.
    Cáceres NE; Harris NB; Wellehan JF; Feng Z; Kapur V; Barletta RG
    J Bacteriol; 1997 Aug; 179(16):5046-55. PubMed ID: 9260945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to D-cycloserine in the tubercle bacilli: mutation rate and transport of alanine in parental cells and drug-resistant mutants.
    David HL
    Appl Microbiol; 1971 May; 21(5):888-92. PubMed ID: 4995732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis underlying Mycobacterium tuberculosis D-cycloserine resistance. Is there a role for ubiquinone and menaquinone metabolic pathways?
    Hong W; Chen L; Xie J
    Expert Opin Ther Targets; 2014 Jun; 18(6):691-701. PubMed ID: 24773568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fitness-compensatory mutations facilitate the spread of drug-resistant F15/LAM4/KZN and F28 Mycobacterium tuberculosis strains in KwaZulu-Natal, South Africa.
    Naidoo CC; Pillay M
    J Genet; 2017 Sep; 96(4):599-612. PubMed ID: 28947708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Insight into Mechanisms of Reversion of Antibiotic Resistance in Multidrug Resistant
    Ilin AI; Kulmanov ME; Korotetskiy IS; Islamov RA; Akhmetova GK; Lankina MV; Reva ON
    Front Cell Infect Microbiol; 2017; 7():151. PubMed ID: 28534009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis.
    Gagneux S; Long CD; Small PM; Van T; Schoolnik GK; Bohannan BJ
    Science; 2006 Jun; 312(5782):1944-6. PubMed ID: 16809538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning of a D-cycloserine resistance gene from D-cycloserine-producing Streptomyces garyphalus.
    Matsuo H; Kumagai T; Mori K; Sugiyama M
    J Antibiot (Tokyo); 2003 Sep; 56(9):762-7. PubMed ID: 14632285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis.
    Knight GM; Colijn C; Shrestha S; Fofana M; Cobelens F; White RG; Dowdy DW; Cohen T
    Clin Infect Dis; 2015 Oct; 61Suppl 3(Suppl 3):S147-54. PubMed ID: 26409276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.
    Maus CE; Plikaytis BB; Shinnick TM
    Antimicrob Agents Chemother; 2005 Feb; 49(2):571-7. PubMed ID: 15673735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of action of antituberculous drugs and mechanisms of drug resistance in Mycobacterium tuberculosis.
    Rastogi N; David HL
    Res Microbiol; 1993 Feb; 144(2):133-43. PubMed ID: 8337471
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of rifampin-resistant genotypes in Mycobacterium tuberculosis by reverse hybridization assay.
    Maschmann Rde A; Verza M; Silva MS; Sperhacke RD; Ribeiro MO; Suffys PN; Gomes HM; Tortoli E; Marcelli F; Zaha A; Rossetti ML
    Mem Inst Oswaldo Cruz; 2011 Mar; 106(2):139-45. PubMed ID: 21537671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of 4-Amino-Thieno[2,3-
    Harrison GA; Mayer Bridwell AE; Singh M; Jayaraman K; Weiss LA; Kinsella RL; Aneke JS; Flentie K; Schene ME; Gaggioli M; Solomon SD; Wildman SA; Meyers MJ; Stallings CL
    mSphere; 2019 Sep; 4(5):. PubMed ID: 31511370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Well Do Routine Molecular Diagnostics Detect Rifampin Heteroresistance in Mycobacterium tuberculosis?
    Ng KCS; Supply P; Cobelens FGJ; Gaudin C; Gonzalez-Martin J; de Jong BC; Rigouts L
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31413081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Genomic Analysis of Two Clonally Related Multidrug Resistant
    Leung KS; Siu GK; Tam KK; To SW; Rajwani R; Ho PL; Wong SS; Zhao WW; Ma OC; Yam WC
    Front Cell Infect Microbiol; 2017; 7():478. PubMed ID: 29188195
    [No Abstract]   [Full Text] [Related]  

  • 20. Double mutation in DNA gyrase confers moxifloxacin resistance and decreased fitness of Mycobacterium smegmatis.
    Luo T; Yuan J; Peng X; Yang G; Mi Y; Sun C; Wang C; Zhang C; Bao L
    J Antimicrob Chemother; 2017 Jul; 72(7):1893-1900. PubMed ID: 28387828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.